Concept information
Preferred term
Methoxamine
Type
-
mesh:Descriptor
Definition
- An alpha-1 adrenergic agonist that causes prolonged peripheral VASOCONSTRICTION.
Broader concept
Entry terms
- 390-28-3 (Methoxamine)
- 61-16-5 (HCl)
- 8MB4MJ9R7L
- Benzenemethanol, alpha-(1-aminoethyl)-2,5-dimethoxy-
- HUQ1KC1YLI
- Methoxamedrin
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
390-28-3 (Methoxamine)
-
61-16-5 (HCl)
-
8MB4MJ9R7L
-
Benzenemethanol, alpha-(1-aminoethyl)-2,5-dimethoxy-
-
HUQ1KC1YLI
-
Methoxamédrine
URI
http://data.loterre.fr/ark:/67375/JVR-B6QPHX17-X
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}